Reemergence of mumps

Korean Journal of Pediatrics

Volumn 53, Issue 5, 2010, Pages 623-628

  Choi, Kyong Min ^a  

^a Kwandong University College of Medicine   (South Korea)

Author keywords

Mumps; Outbreak; Vaccination

Indexed keywords

EID: 79951710215     PISSN: 17381061     EISSN: 20927258     Source Type: Journal    
DOI: 10.3345/kjp.2010.53.5.623     Document Type: Review

References (43)

1. Peltola H, Davidkin I, Paunio M, Valle M, Leinikki P, Heinonen OP. Mumps and rubella eliminated from Finland. JAMA 2000;284:2643-7.
2. Ong G, Goh KT, Ma S, Chew SK. Comparative efficacy of Rubini, Jeryl-Lynn and Urabe mumps vaccine in an Asian population. J Infect 2005;51:294-8.
3. Atrasheuskaya AV, Blatun EM, Kulak MV, Atrasheuskaya A, Karpov IA, Rubin S, et al. Investigation of mumps vaccine failures in Minsk, Belarus, 2001-2003. Vaccine 2007;25:4651-8.
4. Cohen C, White JM, Savage EJ, Glynn JR, Choi Y, Andrews N, et al. Vaccine effectiveness estimates, 2004-2005 mumps outbreak, England. Emerg Infect Dis 2007;13:12-7.
5. Peltola H, Kulkarni PS, Kapre SV, Paunio M, Jadhav SS, Dhere RM. Mumps outbreaks in Canada and the United States: time for new thinking on mumps vaccines. Clin Infect Dis 2007;45:459-66.
6. Rubin S, Qi L, Audet S, Sullivan B, Carbone K, Bellini W, et al. Antibody induced by immunization with the Jeryl Lynn mumps vaccine strain effectively neutralizes a heterologous wild-type mumps virus associated with a large outbreak. J Infect Dis 2008;198:508-15.
7. Mortimer PP. Mumps prophylaxis in the light of a new test for antibody. Br Med J 1978;2:1523-4.
8. Galazka AM, Robertson SE, Kraigher A. Mumps and mumps vaccine: a global review. Bull World Health Organ 1999;77:3-14.
9. Dayan GH, Quinlisk MP, Parker AA, Barskey AE, Harris ML, Schwartz JM, et al. Recent resurgence of mumps in the United States. N Engl J Med 2008;358:1580-9.
10. Stein-Zamir C, Shoob H, Abramson N, Tallen-Gozani E, Sokolov I, Zentner G. Mumps outbreak in Jerusalem affecting mainly male adolescents. Euro Surveill [Internet]. 2009 Dec 17 [cited];14(50):pii=19440. Available from: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=19440.
11. Brockhoff HJ, Mollema L, Sonder GJ, Postema CA, van Binnendijk RS, Kohl RH, et al. Mumps outbreak in a highly vaccinated student population, The Netherlands, 2004. Vaccine 2010;28:2932-6
12. Schwarz NG, Bernard H, Melnic A, Bucov V, Caterinciuc N, Ander Heiden M, et al. Mumps outbreak in the Republic of Moldova, 2007-2008. Pediatr Infect Dis J 2010 Epub ahead of print
13. Lee JY, Na BK, Kim JH, Lee JS, Park JW, Shin GC, et al. Regional outbreak of mumps due to genotype H in Korea in 1999. J Med Virol 2004;73:85-90.
14. Park DW, Nam M-H, Kim JY, Kim HJ, Sohn JW, Cho Y, et al. Mumps outbreak in a highly vaccinated school population: assessment of secondary vaccine failure using IgG avidity measurements. Vaccine 2007;25:4665-70.
15. Mumps epidemic--United kingdom, 2004-2005. MMWR Morb Mortal Wkly Rep 2006;55:173-5.
16. Brief report: update: mumps activity--United States, January 1-October 7, 2006. MMWR Morb Mortal Wkly Rep 2006;55:1152-3.
17. Hviid A, Rubin S, Muhlemann K. Mumps. Lancet 2008;371:932-44.
18. Barskey AE, Glasser JW, LeBaron CW. Mumps resurgences in the United States: A historical perspective on unexpected elements. Vaccine 2009;27:6186-95.
19. Update: mumps outbreak - New York and New Jersey, June 2009- January 2010. MMWR Morb Mortal Wkly Rep 2010;59:125-9.
20. Bartak V. Sperm count, morphology and motility after unilateral mumps orchitis. J Reprod Fertil 1973;32:491-4.
21. Beard CM, Benson RC, Jr., Kelalis PP, Elveback LR, Kurland LT. The incidence and outcome of mumps orchitis in Rochester, Minnesota, 1935 to 1974. Mayo Clin Proc 1977;52:3-7.
22. A retrospective survey of the complications of mumps. J R Coll Gen Pract 1974;24:552-6.
23. Utz JP, Houk VN, Alling DW. Clinical and laboratory studies of mumps. N Engl J Med 1964;270:1283-6.
24. Cochi SL, Preblud SR, Orenstein WA. Perspectives on the relative resurgence of mumps in the United States. Am J Dis Child 1988;142:499-507.
25. Sever J, White LR. Intrauterine viral infections. Annu Rev Med 1968;19:471-86.
26. M. Congenital malformations following chickenpox, measles, mumps, and hepatitis. Results of a cohort study. JAMA 1973;226:1521-4.
27. Gans H, Yasukawa L, Rinki M, DeHovitz R, Forghani B, Beeler J, et al. Immune responses to measles and mumps vaccination of infants at 6, 9, and 12 months. J Infect Dis 2001;184:817-26.
28. Jokinen S, Osterlund P, Julkunen I, Davidkin I. Cellular immunity to mumps virus in young adults 21 years after measles-mumps-rubella vaccination. J Infect Dis 2007;196:861-7.
29. Guy RJ, Andrews RM, Kelly HA, Leydon JA, Riddell MA, Lambert SB, et al. Mumps and rubella: a year of enhanced surveillance and laboratory testing. Epidemiol Infect 2004;132:391-8.
30. Davidkin I, Jokinen S, Paananen A, Leinikki P, Peltola H. Etiology of Mumps-like Illnesses in children and adolescents vaccinated for measles, mumps, and rubella. J Infect Dis 2005;191:719-23.
31. Lane TM, Hines J. The management of mumps orchitis. BJU Int 2006;97:1-2.
32. Erpenbach KH. Systemic treatment with interferon-alpha 2B: an effective method to prevent sterility after bilateral mumps orchitis. J Urol 1991;146:54-6.
33. Buyukavci M, Yildirim ZK, Tan H. High-dose IVIG therapy in a child with idiopathic thrombocytopenic purpura associated with mumps. J Pediatr Hematol Oncol 2005;27:56-7.
34. Sonmez FM, Odemis E, Ahmetoglu A, Ayvaz A. Brainstem encephalitis and acute disseminated encephalomyelitis following mumps. Pediatr Neurol 2004;30:132-4.
35. Bajaj NP, Rose P, Clifford-Jones R, Hughes PJ. Acute transverse myelitis and Guillain- Barré overlap syndrome with serological evidence for mumps viraemia. Acta Neurol Scand 2001;104:239-42.
36. Nokes DJ, Anderson RM. Measles, mumps, and rubella vaccine: what coverage to block transmission? Lancet 1988;2:1374.
37. World Health Organization. Mumps virus vaccines. Wkly Epidemiol Rec 2001;76:346-55.
38. Hilleman MR, Weibel RE, Buynak EB, Stokes J, Jr., Whitman JE, Jr. Live attenuated mumps-virus vaccine. IV. Protective efficacy as measured in a field evaluation. N Engl J Med 1967;276:252-8.
39. Sugg WC, Finger JA, Levine RH, Pagano JS. Field evaluation of live virus mumps vaccine. J Pediatr 1968;72:461-6.
40. Miller E, Hill A, Morgan-Capner P, Forsey T, Rush M. Antibodies to measles, mumps and rubella in UK children 4 years after vaccination with different MMR vaccines. Vaccine 1995;13:799-802.
41. Davidkin I, Valle M, Julkunen I. Persistence of anti-mumps virus antibodies after a two-dose MMR vaccination. A nine-year follow-up. Vaccine 1995;13:1617-22.
42. Harling R, White JM, Ramsay ME, Macsween KF, Bosch Cvd. The effectiveness of the mumps component of the MMR vaccine: a case control study. Vaccine 2005;23:4070-4.
43. Narita M, Matsuzono Y, Takekoshi Y, Yamada S, Itakura O, Kubota M, et al. Analysis of mumps vaccine failure by means of avidity testing for mumps virus-specific immunoglobulin G. Clin Diagn Lab Immunol 1998;5:799-803.